{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:55:49Z","timestamp":1790700949654,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00277-022-04936-2","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T08:02:37Z","timestamp":1659772957000},"page":"2159-2167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura"],"prefix":"10.1007","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7789-4175","authenticated-orcid":false,"given":"Jenna","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Potugari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall A.","family":"Mazepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhail","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison R.","family":"Moliterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Vaught","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Burwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"issue":"22","key":"4936_CR1","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","volume":"339","author":"HM Tsai","year":"1998","unstructured":"Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339(22):1585\u20131594","journal-title":"N Engl J Med"},{"issue":"5","key":"4936_CR2","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/trf.14060","volume":"57","author":"T Falter","year":"2017","unstructured":"Falter T, Schmitt V, Herold S, Weyer V, von Auer C, Wagner S et al (2017) Depression and cognitive deficits as long-term consequences of thrombotic thrombocytopenic purpura. Transfusion 57(5):1152\u20131162","journal-title":"Transfusion"},{"issue":"25","key":"4936_CR3","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1182\/blood-2015-05-643338","volume":"126","author":"MA Sonneveld","year":"2015","unstructured":"Sonneveld MA, de Maat MP, Portegies ML, Kavousi M, Hofman A, Turecek PL et al (2015) Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood 126(25):2739\u20132746","journal-title":"Blood"},{"issue":"6","key":"4936_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"GA Rock","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC et al (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325(6):393\u20137","journal-title":"N Engl J Med"},{"issue":"6","key":"4936_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1056\/NEJM199108083250605","volume":"325","author":"WR Bell","year":"1991","unstructured":"Bell WR, Braine HG, Ness PM, Kickler TS (1991) Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325(6):398\u2013403","journal-title":"N Engl J Med"},{"issue":"6","key":"4936_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/00005792-198111000-00003","volume":"60","author":"RL Ridolfi","year":"1981","unstructured":"Ridolfi RL, Bell WR (1981) Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine Baltimore 60(6):413\u201328","journal-title":"Medicine Baltimore"},{"issue":"8","key":"4936_CR7","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1537-2995.2004.03422.x","volume":"44","author":"SK Vesely","year":"2004","unstructured":"Vesely SK, Li X, McMinn JR, Terrell DR, George JN (2004) Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 44(8):1149\u20131158","journal-title":"Transfusion"},{"issue":"5","key":"4936_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","volume":"142","author":"M Scully","year":"2008","unstructured":"Scully M, Yarranton H, Liesner R, Cavenagh J, Hunt B, Benjamin S et al (2008) Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol 142(5):819\u2013826","journal-title":"Br J Haematol"},{"issue":"11","key":"4936_CR9","doi-asserted-by":"publisher","first-page":"E316","DOI":"10.1002\/ajh.25964","volume":"95","author":"R Kasht","year":"2020","unstructured":"Kasht R, Borogovac A, George JN (2020) Frequency and severity of pregnancy complications in women with hereditary thrombotic thrombocytopenic purpura. Am J Hematol 95(11):E316\u2013E318","journal-title":"Am J Hematol"},{"issue":"10","key":"4936_CR10","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/pbc.24612","volume":"60","author":"JA Reese","year":"2013","unstructured":"Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN (2013) Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer 60(10):1676\u20131682","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"4936_CR11","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1182\/blood-2013-04-496752","volume":"122","author":"CC Deford","year":"2013","unstructured":"Deford CC, Reese JA, Schwartz LH, Perdue JJ, Kremer Hovinga JA, L\u00e4mmle B et al (2013) Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood 122(12):2023\u20132029 (quiz 142)","journal-title":"Blood"},{"issue":"1","key":"4936_CR12","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1182\/asheducation-2018.1.548","volume":"2018","author":"JN George","year":"2018","unstructured":"George JN (2018) TTP: long-term outcomes following recovery. Hematology Am Soc Hematol Educ Program 2018(1):548\u2013552","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"42","key":"4936_CR13","doi-asserted-by":"publisher","first-page":"e1598-e","DOI":"10.1097\/MD.0000000000001598","volume":"94","author":"M Roriz","year":"2015","unstructured":"Roriz M, Landais M, Desprez J, Barbet C, Azoulay E, Galicier L et al (2015) Risk factors for autoimmune diseases development after thrombotic thrombocytopenic purpura. Medicine 94(42):e1598-e","journal-title":"Medicine"},{"issue":"11","key":"4936_CR14","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1182\/blood-2013-11-538900","volume":"123","author":"Y Jiang","year":"2014","unstructured":"Jiang Y, McIntosh JJ, Reese JA, Deford CC, Kremer Hovinga JA, Lammle B et al (2014) Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood 123(11):1674\u20131680","journal-title":"Blood"},{"issue":"6","key":"4936_CR15","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","unstructured":"Gestational Hypertension and Preeclampsia (2020) ACOG Practice Bulletin, Number 222. Obstet Gynecol 135(6):e237\u2013e260","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"4936_CR16","doi-asserted-by":"publisher","first-page":"S216","DOI":"10.1111\/jth.12953","volume":"13","author":"SK Vesely","year":"2015","unstructured":"Vesely SK (2015) Life after acquired thrombotic thrombocytopenic purpura: morbidity, mortality, and risks during pregnancy. J Thromb Haemost 13(Suppl 1):S216\u2013S222","journal-title":"J Thromb Haemost"},{"issue":"6","key":"4936_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/01.mbc.0000240918.65306.20","volume":"17","author":"M Scully","year":"2006","unstructured":"Scully M, Starke R, Lee R, Mackie I, Machin S, Cohen H (2006) Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagul Fibrinolysis 17(6):459\u2013463","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"4936_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","volume":"124","author":"M Scully","year":"2014","unstructured":"Scully M, Thomas M, Underwood M, Watson H, Langley K, Camilleri RS et al (2014) Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood 124(2):211\u2013219","journal-title":"Blood"},{"issue":"2","key":"4936_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/GCO.0b013e32835e0ef5","volume":"25","author":"JO Lo","year":"2013","unstructured":"Lo JO, Mission JF, Caughey AB (2013) Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol 25(2):124\u2013132","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"6","key":"4936_CR20","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1097\/AOG.0b013e3181a45b25","volume":"113","author":"EV Kuklina","year":"2009","unstructured":"Kuklina EV, Ayala C, Callaghan WM (2009) Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 113(6):1299\u20131306","journal-title":"Obstet Gynecol"},{"issue":"5","key":"4936_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ajh.2008.20","volume":"21","author":"AB Wallis","year":"2008","unstructured":"Wallis AB, Saftlas AF, Hsia J, Atrash HK (2008) Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987\u20132004. Am J Hypertens 21(5):521\u2013526","journal-title":"Am J Hypertens"},{"issue":"1","key":"4936_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.transci.2010.05.002","volume":"43","author":"K Abou-Nassar","year":"2010","unstructured":"Abou-Nassar K, Karsh J, Giulivi A, Allan D (2010) Successful prevention of thrombotic thrombocytopenic purpura (TTP) relapse using monthly prophylactic plasma exchanges throughout pregnancy in a patient with systemic lupus erythematosus and a prior history of refractory TTP and recurrent fetal loss. Transfus Apher Sci 43(1):29\u201331","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"4936_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1423-0410.2004.00560.x","volume":"87","author":"M Castella","year":"2004","unstructured":"Castella M, Pujol M, Julia A, Massague I, Bueno J, Ramon Grifols J et al (2004) Thrombotic thrombocytopenic purpura and pregnancy: a review of ten cases. Vox Sang 87(4):287\u2013290","journal-title":"Vox Sang"},{"issue":"2","key":"4936_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0301-2115(03)00199-4","volume":"111","author":"AS Ducloy-Bouthors","year":"2003","unstructured":"Ducloy-Bouthors AS, Caron C, Subtil D, Provot F, Tournoys A, Wibau B et al (2003) Thrombotic thrombocytopenic purpura: medical and biological monitoring of six pregnancies. Eur J Obstet Gynecol Reprod Biol 111(2):146\u2013152","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4936_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13023-014-0193-6","volume":"9","author":"B Ferrari","year":"2014","unstructured":"Ferrari B, Maino A, Lotta LA, Artoni A, Pontiggia S, Trisolini SM et al (2014) Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study. Orphanet J Rare Dis 9:193","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"4936_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1160\/TH07-12-0739","volume":"101","author":"J Gerth","year":"2009","unstructured":"Gerth J, Schleussner E, Kentouche K, Busch M, Seifert M, Wolf G (2009) Pregnancy-associated thrombotic thrombocytopenic purpura. Thromb Haemost 101(2):248\u2013251","journal-title":"Thromb Haemost"},{"issue":"3","key":"4936_CR27","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1111\/bjh.17833","volume":"196","author":"L Kuhne","year":"2022","unstructured":"Kuhne L, Volker LA, Hagmann H, Hagele H, Osterholt T, Eichenauer DA et al (2022) First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy. Br J Haematol 196(3):e30\u2013e33","journal-title":"Br J Haematol"},{"issue":"7","key":"4936_CR28","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1093\/ndt\/gfq228","volume":"25","author":"K Lam","year":"2010","unstructured":"Lam K, Martlew V, Walkinshaw S, Alfirevic Z, Howse M (2010) Successful management of recurrent pregnancy-related thrombotic thrombocytopaenia purpura in a renal transplant recipient. Nephrol Dial Transplant 25(7):2378\u20132380","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"4936_CR29","first-page":"s137","volume":"12","author":"G Lucania","year":"2014","unstructured":"Lucania G, Camiolo E, Carmina MG, Fiandaca T, Indovina A, Malato A et al (2014) Multidisciplinary approach in pregnancy-associated thrombotic thrombocytopenic purpura: a case report. Blood Transfus 12(Suppl 1):s137\u2013s140","journal-title":"Blood Transfus"},{"key":"4936_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.thromres.2020.06.020","volume":"194","author":"S Marcellini Antonio","year":"2020","unstructured":"Marcellini Antonio S, Valencia Castillo S, Diaz Valdes J, Torres Tienza A, Zato Hernandez E, Garcia Mateo A et al (2020) Clinical management and follow-up of relapsed immune thrombotic thrombocytopenic purpura during pregnancy: a case report. Thromb Res 194:91\u201394","journal-title":"Thromb Res"},{"issue":"9\u201310","key":"4936_CR31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2298\/MPNS1210436N","volume":"65","author":"M Nikolaou","year":"2012","unstructured":"Nikolaou M, Karakantza M, Adonakis G, Theodorou G, Zoumbos N, Decavalas G (2012) A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy. Med Pregl 65(9\u201310):436\u2013439","journal-title":"Med Pregl"},{"issue":"5","key":"4936_CR32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10067-012-2156-4","volume":"32","author":"M Ojeda-Uribe","year":"2013","unstructured":"Ojeda-Uribe M, Afif N, Dahan E, Sparsa L, Haby C, Sibilia J et al (2013) Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases. Clin Rheumatol 32(5):695\u2013700","journal-title":"Clin Rheumatol"},{"issue":"3","key":"4936_CR33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.transci.2016.08.002","volume":"55","author":"AM Panaitescu","year":"2016","unstructured":"Panaitescu AM, Stoia R, Ciobanu AM, Demetrian M, Peltecu G (2016) Pregnancy shortly after an acute episode of severe acquired thrombotic thrombocytopenic purpura. Transfus Apher Sci 55(3):308\u2013310","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"4936_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1055\/s-0032-1305799","volume":"2","author":"T Patrick","year":"2012","unstructured":"Patrick T, Carlan SJ, Najera JE, Eastwood J (2012) Management of thrombotic thrombocytopenic purpura with autoantibodies to ADAMTS-13 and concurrent preeclampsia in pregnancy: multidisciplinary team approach. AJP Rep 2(1):37\u201338","journal-title":"AJP Rep"},{"issue":"2","key":"4936_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2141.2010.08558.x","volume":"153","author":"R Raman","year":"2011","unstructured":"Raman R, Yang S, Wu HM, Cataland SR (2011) ADAMTS13 activity and the risk of thrombotic thrombocytopenic purpura relapse in pregnancy. Br J Haematol 153(2):277\u2013279","journal-title":"Br J Haematol"},{"issue":"9","key":"4936_CR36","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/ATVBAHA.117.309735","volume":"37","author":"J Xiao","year":"2017","unstructured":"Xiao J, Feng Y, Li X, Li W, Fan L, Liu J et al (2017) Expression of ADAMTS13 in normal and abnormal placentae and its potential role in angiogenesis and placenta development. Arterioscler Thromb Vasc Biol 37(9):1748\u20131756","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"4936_CR37","doi-asserted-by":"publisher","first-page":"544 el","DOI":"10.1016\/j.ajog.2013.08.019","volume":"209","author":"S Lisonkova","year":"2013","unstructured":"Lisonkova S, Joseph KS (2013) Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 209(6):544 el-e12","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"4936_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11239-020-02133-4","volume":"51","author":"A Rottenstreich","year":"2021","unstructured":"Rottenstreich A, Dor S, Keren-Politansky A, Sarig G, Nadir Y, Ellis M et al (2021) Pregnancy and non-pregnancy related immune thrombotic thrombocytopenic purpura in women of reproductive age. J Thromb Thrombolysis 51(1):187\u2013193","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"4936_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ajog.2008.03.011","volume":"199","author":"JN Martin Jr","year":"2008","unstructured":"Martin JN Jr, Bailey AP, Rehberg JF, Owens MT, Keiser SD, May WL (2008) Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955\u20132006. Am J Obstet Gynecol 199(2):98\u2013104","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"4936_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2105\/AJPH.2005.068577","volume":"97","author":"M Tanaka","year":"2007","unstructured":"Tanaka M, Jaamaa G, Kaiser M, Hills E, Soim A, Zhu M et al (2007) Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health 97(1):163\u2013170","journal-title":"Am J Public Health"},{"issue":"12","key":"4936_CR41","doi-asserted-by":"publisher","first-page":"e2139564","DOI":"10.1001\/jamanetworkopen.2021.39564","volume":"4","author":"E Boakye","year":"2021","unstructured":"Boakye E, Kwapong YA, Obisesan O, Ogunwole SM, Hays AG, Nasir K et al (2021) Nativity-related disparities in preeclampsia and cardiovascular disease risk among a racially diverse cohort of US women. JAMA Netw Open 4(12):e2139564","journal-title":"JAMA Netw Open"},{"key":"4936_CR42","doi-asserted-by":"publisher","first-page":"i1753","DOI":"10.1136\/bmj.i1753","volume":"353","author":"E Bartsch","year":"2016","unstructured":"Bartsch E, Medcalf KE, Park AL, Ray JG (2016) High Risk of Pre-eclampsia Identification G. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ 353:i1753","journal-title":"BMJ"},{"issue":"7","key":"4936_CR43","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1161\/ATVBAHA.111.223610","volume":"31","author":"A Stepanian","year":"2011","unstructured":"Stepanian A, Cohen-Moatti M, Sanglier T, Legendre P, Ameziane N, Tsatsaris V et al (2011) Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology. Arterioscler Thromb Vasc Biol 31(7):1703\u20131709","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"4936_CR44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1179\/1607845412Y.0000000070","volume":"18","author":"S Aref","year":"2013","unstructured":"Aref S, Goda H (2013) Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia. Hematology 18(4):237\u2013241","journal-title":"Hematology"},{"issue":"23\u201324","key":"4936_CR45","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.cca.2011.07.030","volume":"412","author":"PN Alpoim","year":"2011","unstructured":"Alpoim PN, Gomes KB, Godoi LC, Rios DR, Carvalho MG, Fernandes AP et al (2011) ADAMTS13, FVIII, von Willebrand factor, ABO blood group assessment in preeclampsia. Clin Chim Acta 412(23\u201324):2162\u20136","journal-title":"Clin Chim Acta"},{"issue":"3","key":"4936_CR46","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","volume":"158","author":"M Scully","year":"2012","unstructured":"Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F et al (2012) Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 158(3):323\u2013335","journal-title":"Br J Haematol"},{"issue":"12","key":"4936_CR47","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1001\/jama.2021.8551","volume":"326","author":"JT Henderson","year":"2021","unstructured":"Henderson JT, Vesco KK, Senger CA, Thomas RG, Redmond N (2021) Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 326(12):1192\u20131206","journal-title":"JAMA"},{"key":"4936_CR48","doi-asserted-by":"crossref","unstructured":"Duley L, Meher S, Hunter KE, Seidler AL, Askie LM (2019) Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019(10)","DOI":"10.1002\/14651858.CD004659.pub3"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04936-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04936-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04936-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T06:06:23Z","timestamp":1662703583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04936-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["4936"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04936-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"17 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Johns Hopkins Institutional Review Board as a retrospective study with waiver of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"S. Chaturvedi reports participation in advisory boards for Alexion, Sanofi Genzyme, Sobi, and UCB. MA Mazepa reports payment for lecture and travel by Sanofi Genzyme. The other authors have no competing interests. S. Chaturvedi and M.A. Mazepa serve on the Board of Directors for the United States Thrombotic Microangiopathy Consortium.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}